Hill AT - Search Results

1

Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study.

Loebinger MR, Polverino E, Chalmers JD, Tiddens HAWM, Goossens H, Tunney M, Ringshausen FC, Hill AT, Pathan R, Angyalosi G, Blasi F, Elborn SJ, Haworth CS; iBEST-1 Trial Team. Loebinger MR, et al. Among authors: hill at. Eur Respir J. 2021 Jan 5;57(1):2001451. doi: 10.1183/13993003.01451-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 32855225 Free article. Clinical Trial.

2

C-reactive protein is an independent predictor of severity in community-acquired pneumonia.

Chalmers JD, Singanayagam A, Hill AT. Chalmers JD, et al. Among authors: hill at. Am J Med. 2008 Mar;121(3):219-25. doi: 10.1016/j.amjmed.2007.10.033. Am J Med. 2008. PMID: 18328306

3

Systolic blood pressure is superior to other haemodynamic predictors of outcome in community acquired pneumonia.

Chalmers JD, Singanayagam A, Hill AT. Chalmers JD, et al. Among authors: hill at. Thorax. 2008 Aug;63(8):698-702. doi: 10.1136/thx.2008.095562. Epub 2008 May 20. Thorax. 2008. PMID: 18492742

4

Assessing response to treatment of exacerbations of bronchiectasis in adults.

Murray MP, Turnbull K, Macquarrie S, Hill AT. Murray MP, et al. Among authors: hill at. Eur Respir J. 2009 Feb;33(2):312-8. doi: 10.1183/09031936.00122508. Epub 2008 Oct 1. Eur Respir J. 2009. PMID: 18829674 Free article.

5

A powerful new severity score for community-acquired pneumonia but will anyone use it?

Chalmers JD, Hill AT. Chalmers JD, et al. Among authors: hill at. Clin Infect Dis. 2008 Nov 15;47(10):1363; author reply 1364. doi: 10.1086/592747. Clin Infect Dis. 2008. PMID: 18922077 No abstract available.

6

Prior statin use is associated with improved outcomes in community-acquired pneumonia.

Chalmers JD, Singanayagam A, Murray MP, Hill AT. Chalmers JD, et al. Among authors: hill at. Am J Med. 2008 Nov;121(11):1002-1007.e1. doi: 10.1016/j.amjmed.2008.06.030. Am J Med. 2008. PMID: 18954848

7

Predicting the need for mechanical ventilation and/or inotropic support for young adults admitted to the hospital with community-acquired pneumonia.

Chalmers JD, Singanayagam A, Hill AT. Chalmers JD, et al. Among authors: hill at. Clin Infect Dis. 2008 Dec 15;47(12):1571-4. doi: 10.1086/593195. Clin Infect Dis. 2008. PMID: 18991510

8

Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia.

Chalmers JD, Singanayagam A, Murray MP, Scally C, Fawzi A, Hill AT. Chalmers JD, et al. Among authors: hill at. Thorax. 2009 Jul;64(7):592-7. doi: 10.1136/thx.2008.105080. Epub 2009 Jan 8. Thorax. 2009. PMID: 19131449

9

Admission D-dimer can identify low-risk patients with community-acquired pneumonia.

Chalmers JD, Singanayagam A, Scally C, Hill AT. Chalmers JD, et al. Among authors: hill at. Ann Emerg Med. 2009 May;53(5):633-8. doi: 10.1016/j.annemergmed.2008.12.022. Epub 2009 Feb 7. Ann Emerg Med. 2009. PMID: 19201061

10

Severity assessment in community-acquired pneumonia: a review.

Singanayagam A, Chalmers JD, Hill AT. Singanayagam A, et al. Among authors: hill at. QJM. 2009 Jun;102(6):379-88. doi: 10.1093/qjmed/hcp027. Epub 2009 Mar 18. QJM. 2009. PMID: 19299247 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters